Granada M L, Murillo J, Lucas A, Salinas I, Llopis M A, Castells I, Foz M, Sanmartí A
Department of Clinical Biochemistry, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Spain.
Eur J Endocrinol. 2000 Mar;142(3):243-53. doi: 10.1530/eje.0.1420243.
To analyse the diagnostic role of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH (uGH) excretion in adult GH deficiency (GHD).
Twenty-seven adults (age range: 18-71 years) with severe GHD, defined by a peak GH response to an insulin tolerance test below 3microg/l in patients with at least one additional pituitary hypofunction. Reference values were established from a selected age- and body mass index-matched population (154 healthy adults grouped in four age groups).
IGF-I and IGFBP-3 were measured by RIA (Nichols) and results expressed as standard deviation (s.d.) scores from our reference population and assay normative data (s.d. score Nichols). uGH was measured by IRMA.
Within the control group, IGF-I, IGFBP-3, IGF-I/IGFBP-3 ratio standardisation regarding our control population and IGF-I with respect to the assay normative data resulted in disappearance of age-related differences. However, IGFBP-3 s.d. score Nichols resulted in mean values between +1.4 and +2.5 s.d. score. Greatest diagnostic efficiency was for IGF-I standardised with respect to our controls (97.2%), followed by s.d. score IGFBP-3 (92.9%). s.d. score IGF/IGFBP-3 ratio and uGH showed poor diagnostic efficiency. Any combination of at least two abnormal parameters raised specificity to 100%. IGF-I standardised with respect to assay reference (s.d. score Nichols) showed similar diagnostic value (95.0%) whereas IGFBP-3 showed low sensitivity (33. 3%). Within the GHD patients, those with three or more additional deficiencies had lower s.d. score IGF-I than those with only two or one.
We underline the importance of an appropriate reference population for correct interpretation of GH secretion markers. Considering our results, specificity obtained with two simultaneous abnormal parameters when referred to an adequate reference population may add valuable information to alternative GH stimulation tests to confirm adult GHD.
分析血清胰岛素样生长因子-I(IGF-I)、胰岛素样生长因子结合蛋白-3(IGFBP-3)、IGF-I/IGFBP-3摩尔比及尿生长激素(uGH)排泄在成人生长激素缺乏症(GHD)中的诊断作用。
27例成年患者(年龄范围:18 - 71岁),患有严重GHD,定义为在至少存在一项其他垂体功能减退的患者中,胰岛素耐量试验的生长激素峰值反应低于3μg/L。参考值来自选定的年龄和体重指数匹配人群(154名健康成年人分为四个年龄组)。
采用放射免疫分析法(RIA,Nichols公司)测定IGF-I和IGFBP-3,并根据我们的参考人群和检测规范数据将结果表示为标准差(s.d.)评分(Nichols公司的s.d.评分)。采用免疫放射分析法(IRMA)测定uGH。
在对照组中,关于我们的对照人群对IGF-I、IGFBP-3、IGF-I/IGFBP-3比值进行标准化,以及关于检测规范数据对IGF-I进行标准化后,年龄相关差异消失。然而,Nichols公司的IGFBP-3的s.d.评分得出的平均值在+1.4至+2.5个s.d.评分之间。相对于我们的对照组进行标准化的IGF-I的诊断效率最高(97.2%),其次是IGFBP-3的s.d.评分(92.9%)。IGF/IGFBP-3比值的s.d.评分和uGH的诊断效率较低。至少两个异常参数的任何组合可将特异性提高到100%。相对于检测参考值(Nichols公司的s.d.评分)进行标准化的IGF-I显示出相似的诊断价值(95.0%),而IGFBP-3显示出低敏感性(33.3%)。在GHD患者中,患有三种或更多其他缺陷的患者的IGF-I的s.d.评分低于仅患有两种或一种缺陷的患者。
我们强调了合适的参考人群对于正确解释生长激素分泌标志物的重要性。考虑到我们的结果,当参考适当的参考人群时,两个同时出现的异常参数所获得的特异性可能会为替代生长激素刺激试验提供有价值的信息,以确诊成人GHD。